NewsBreak: HIV vaccine candidate induces immune response in early clinical trial: ‘An important step forward’

https://share.newsbreak.com/2fsb3rl3

https://ichgcp.net/news/a-study-of-eod-gt8-60mer-mrna-vaccine-mrna-1644-in-hiv-1-uninfected-adults#amp_tf=From%20%251%24s&aoh=16699404976283&referrer=https%3A%2F%2Fwww.google.com&ampshare=https%3A%2F%2Fichgcp.net%2Fnews%2Fa-study-of-eod-gt8-60mer-mrna-vaccine-mrna-1644-in-hiv-1-uninfected-adults

https://www.sec.gov/Archives/edgar/data/1682852/000168285221000006/mrna-20201231.htm

https://ichgcp.net/news/a-study-of-eod-gt8-60mer-mrna-vaccine-mrna-1644-in-hiv-1-uninfected-adults#amp_tf=From%20%251%24s&aoh=16699404976283&referrer=https%3A%2F%2Fwww.google.com&ampshare=https%3A%2F%2Fichgcp.net%2Fnews%2Fa-study-of-eod-gt8-60mer-mrna-vaccine-mrna-1644-in-hiv-1-uninfected-adults

An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus.

The clinical trial results, published Thursday on World AIDS Day in the journal Science , establish “clinical proof of concept” in support of developing boosting regimens to induce immune responses against HIV infection, for which there is no cure and which can cause acquired immunodeficiency syndrome, known as AIDS.

The vaccine, called eOD-GT8 60mer (mrna-1644) had a “favorable safety profile” and induced broadly neutralizing antibodies in 97%, or all but one, of the 36 recipients, according to the researchers from Scripps Research, the Fred Hutchinson Cancer Center, the National Institutes of Health and other institutions in the United States and Sweden.

Antibodies are proteins made by the immune system to help fight infections, and broadly neutralizing antibodies are known to neutralize many genetic variants of HIV, but they have been difficult to elicit by vaccination.

“Learning how to induce broadly neutralizing antibodies against pathogens with high antigenic diversity, such as HIV, influenza, hepatitis C virus, or the family of betacoronaviruses, represents a grand challenge for rational vaccine design,” the researchers wrote. “Germline-targeting vaccine design offers one potential strategy to meet this challenge.”


Moderna jab patents https://www.modernatx.com/patents open these patents in a browser with a search feature or download and open in an app with a search feature and search things like Triple Helix, ATCG to ATCCCG (666), Thrombin (Snake Venom), PVA (Quantom Dot),Luciferase, Chimera (MultipleDNA Combos), cDNA (SupremeCourt Ruling to own you), Crispr (DNA Slicing), Prions (Poison),HIV, HEK293 (aborted fetal tissue), programmable nanoparticles, self-assembled… you will find them all in there.

https://www.sec.gov/Archives/edgar/data/1682852/000168285221000006/mrna-20201231.htm
https://www.sec.gov/Archives/edgar/data/1682852/000168285221000006/mrna-20201231.htm
https://www.sec.gov/Archives/edgar/data/1682852/000168285221000006/mrna-20201231.htm

The Depopulation Agenda Plan is commencing..

Please repent, carry your cross daily and accept the free gift of Jesus Christ’s Death on the Cross for payment for your sins.

#Yahweh #Yeshua #HolySpirit #LordAlmighty #SovereignLord #Nameaboveallnames #TheWay #TheTruth #TheLife #TheGate #Heaven #KingdomofHeaven #Saved #Glorified #Endtimes #LastDays #FeastofTrumpets #markofthebeast #verseoftheday #birthpains #Judgement #Christian #Christianity #hope #love #Jesus #Christ

Leave a Reply

Powered by WordPress.com.

Up ↑

%d bloggers like this: